Neuropsychiatric disorders and COVID-19
- PMID: 34147173
- PMCID: PMC8216631
- DOI: 10.1016/S2215-0366(21)00172-3
Neuropsychiatric disorders and COVID-19
Conflict of interest statement
I declare no competing interests.
Comment in
-
Neuropsychiatric disorders and COVID-19.Lancet Psychiatry. 2021 Jul;8(7):564-565. doi: 10.1016/S2215-0366(21)00178-4. Lancet Psychiatry. 2021. PMID: 34147174 Free PMC article. No abstract available.
-
Neuropsychiatric disorders and COVID-19 - Authors' reply.Lancet Psychiatry. 2021 Jul;8(7):565-566. doi: 10.1016/S2215-0366(21)00202-9. Lancet Psychiatry. 2021. PMID: 34147175 Free PMC article. No abstract available.
Comment on
-
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.Lancet Psychiatry. 2021 May;8(5):416-427. doi: 10.1016/S2215-0366(21)00084-5. Epub 2021 Apr 6. Lancet Psychiatry. 2021. PMID: 33836148 Free PMC article.
-
Neuropsychiatric disorders and COVID-19.Lancet Psychiatry. 2021 Jul;8(7):563. doi: 10.1016/S2215-0366(21)00177-2. Lancet Psychiatry. 2021. PMID: 34147172 Free PMC article. No abstract available.
References
-
- Finsterer J, Scorza FA. Neuropathy of peripheral nerves in COVID-19 is due to pre-existing risk factors, anti-viral drugs, or bedding on the ICU. Arq Neuropsiqiatr (in press). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
